Substituting a less-expensive hepatitis C core antigen test into the standard 2-step process for diagnosing active hepatitis C virus (HCV) infection could streamline and cut the cost of HCV detection, according to the results of a study published in Annals of Internal Medicine. Dr. J. Morgan Freiman, of the Boston Medical Center, and her colleagues, performed a meta-analysis to determine the sensitivity and specificity associated with each of the 5 HCV core antigen tests. To find out which tests performed best, go to Family Practice News: http://www.familypracticenews.com/specialty-focus/infectious-diseases/single-article-page/new-hcv-test-approach-could-cut-costs-streamline-diagnosis/8d117e35547c3068dfb553f396ff7ed7.html.